Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

New treatments for male hypogonadism are effective and should be personalized.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Chromosomal differences affect how muscle cells respond to testosterone.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

ESR2 gene variations may be linked to female pattern hair loss.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Capsaicin cream quickly relieved itching in two patients with brachioradial pruritus.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Hair can be used to measure cancer-related chemicals noninvasively.

A small percentage of minoxidil users may develop an allergic skin reaction.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.